🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s LRMR Holdings & Trades

First Buy
Q2 2024
Duration Held
10 Quarters
Largest Add
Q2 2026
+1.55 M Shares
Current Position
2.24 M Shares
$7.16 M Value

Cliff Asness's LRMR Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 2.24 M shares of Larimar Therapeutics, Inc. (LRMR) worth $7.16 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this medium-term investment has been held for 10 quarters.

Based on 13F filings, Cliff Asness has maintained a strategic position in LRMR, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 1.55 M shares. Largest reduction occurred in Q3 2026, reducing 130,791 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Larimar Therapeutics (LRMR) Holding Value Over Time

Track share changes against reported price movement

Quarterly Larimar Therapeutics (LRMR) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 -130,791 Reduce 5.52% 2.24 M $3.20
Q2 2026 +1.55 M Add 190.08% 2.37 M $3.05
Q1 2026 +315,266 Add 62.77% 817,517 $4.50
Q4 2025 -60,152 Reduce 10.70% 502,251 $3.81
Q3 2025 +133,915 Add 31.25% 562,403 $3.23
Q2 2025 +316,262 Add 281.81% 428,488 $2.89
Q1 2025 +112,226 New Buy 112,226 $2.15
Q4 2024 -15,712 Sold Out 0 $0.00
Q3 2024 +86 Add 0.55% 15,712 $6.55
Q2 2024 +15,626 New Buy 15,626 $7.25

Cliff Asness's Larimar Therapeutics Investment FAQs

Cliff Asness first purchased Larimar Therapeutics, Inc. (LRMR) in Q2 2024, acquiring 15,626 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Larimar Therapeutics, Inc. (LRMR) for 10 quarters since Q2 2024.

Cliff Asness's largest addition to Larimar Therapeutics, Inc. (LRMR) was in Q2 2026, adding 2,371,414 shares worth $7.23 M.

According to the latest 13F filing for Q3 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,240,623 shares of Larimar Therapeutics, Inc. (LRMR), valued at approximately $7.16 M.

As of the Q3 2026 filing, Larimar Therapeutics, Inc. (LRMR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Larimar Therapeutics, Inc. (LRMR) was 2,371,414 shares, as reported at the end of Q2 2026.